Profile
Armend G.
Håti is the founder of Nordovo Biosciences AS and currently holds the title of Chief Executive Officer.
Armend G. Håti active positions
Companies | Position | Start |
---|---|---|
Nordovo Biosciences AS
Nordovo Biosciences AS BiotechnologyHealth Technology Nordovo Biosciences AS, operating under the name clexbio, is a pre-clinical stage biotech company based in Oslo, Norway. The Norwegian company is focused on developing next-generation tissue-engineered allogeneic grafts for transplant, using its proprietary platform technologies clex and vivoset. clexbio combines advanced bio-fabrication approaches with its proprietary hydrogel technology clex to create breakthrough solutions for tissue engineering and single-cell techniques. The private company was founded by Manuel Schweikle and Armend G. Håti, with Armend G. Håti serving as CEO since incorporation. | Chief Executive Officer | 2019-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Nordovo Biosciences AS
Nordovo Biosciences AS BiotechnologyHealth Technology Nordovo Biosciences AS, operating under the name clexbio, is a pre-clinical stage biotech company based in Oslo, Norway. The Norwegian company is focused on developing next-generation tissue-engineered allogeneic grafts for transplant, using its proprietary platform technologies clex and vivoset. clexbio combines advanced bio-fabrication approaches with its proprietary hydrogel technology clex to create breakthrough solutions for tissue engineering and single-cell techniques. The private company was founded by Manuel Schweikle and Armend G. Håti, with Armend G. Håti serving as CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Armend G. Håti